This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Douglas Howard Finestone, MD; Scott Karl Ober, MD
East Carolina University School of Medicine Greenville, NC

JAMA. 1990;264(22):2869-2870.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Fluoxetine hydrochloride (Prozac) is a new antidepressant characterized by selective inhibition of central nervous system neuronal up-take of serotonin.¹ Fibromyalgia is a common, chronic, rheumatologic pain disorder that may respond to antidepressant treatment.² Only one patient with fibromyalgia has been reported to have been treated successfully with fluoxetine.³ We describe two additional patients.

Case 1.—

A 41-year-old woman was diagnosed in 1987 as having fibromyalgia by the criteria of Yunus et al.⁴ Over the past 3 years, response to trials of trazodone hydrochloride, nortriptyline hydrochloride, and doxepin hydrochloride had been poor. One week after adding 20 mg of fluoxetine hydrochloride every other day to 25 mg of doxepin hydrochloride every evening, the patient reported markedly decreased pain and increased energy, as well as moderately improved sleep. Three months later, she has maintained improvement of her symptoms by taking 20 mg of fluoxetine hydrochloride . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?